Adrienne E Campbell-Washburn Selected Research

Adrienne E Campbell-Washburn Research Topics

2	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2022 - 01/2021
2	Thalassemia 01/2022 - 01/2017
2	Iron Overload 01/2022 - 01/2017
1	Morbid Obesity 08/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Hyperoxia 01/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022
1	Hereditary Spherocytosis 01/2022
1	Cysts 01/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2017
1	Edema (Dropsy) 01/2017
1	Heart Failure 01/2017
1	Myocardial Infarction 01/2017
1	Disease Progression 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 04/2016
1	Amyloidosis 06/2013
1	Amyloid Plaque 06/2013
1	Neoplasm Metastasis (Metastasis) 01/2013
1	Neoplasms (Cancer) 01/2013

2	Oxygen (Dioxygen)IBA 01/2023 - 01/2022
2	lipoarabinomannan (LAM)IBA 01/2022 - 01/2021
2	IronIBA 01/2022 - 01/2017
1	MetalsIBA 08/2023
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2017
1	Oxi 4503IBA 04/2016
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 06/2013
1	Serum Amyloid P-ComponentIBA 06/2013
1	Doxycycline (Periostat)FDA LinkGeneric 06/2013
1	GadoliniumIBA 01/2013
1	Chelating AgentsIBA 01/2013
1	Gadolinium DTPA (Magnevist)FDA Link 01/2013
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2013

3	Therapeutics 01/2017 - 06/2013
1	Blood Transfusion (Blood Transfusions) 01/2017
1	Oral Administration 06/2013